April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Analysis of the VEGFR-1,-2, and -3 distribution in the adult mouse retina and choroid and the effect of Notch activation on these receptors in laser-induced CNV
Author Affiliations & Notes
  • Anne F Alex
    Department of Ophthalmology, University of Muenster, Medical Center, Muenster, Germany
  • Manuel Ehling
    Department of Tissue Morphogenesis, Max-Planck Institute for Molecular Biomedicine, Muenster, Germany
  • Ralf H Adams
    Department of Tissue Morphogenesis, Max-Planck Institute for Molecular Biomedicine, Muenster, Germany
  • Nicole Eter
    Department of Ophthalmology, University of Muenster, Medical Center, Muenster, Germany
  • Footnotes
    Commercial Relationships Anne Alex, Novartis Pharma GmbH (F); Manuel Ehling, None; Ralf Adams, None; Nicole Eter, Allergan (C), Bausch und Lomb (C), Bayer (R), Heidelberg Engineering (R), Novartis (F), Sanofi Aventis (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5989. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anne F Alex, Manuel Ehling, Ralf H Adams, Nicole Eter; Analysis of the VEGFR-1,-2, and -3 distribution in the adult mouse retina and choroid and the effect of Notch activation on these receptors in laser-induced CNV. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5989.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To investigate the distribution of VEGFR-1, -2 and -3 in the mouse retina and choroid in laser-induced CNV and to elucidate the effect of Notch activation on these receptors. Notch activation in endothelium leads to an inhibition of angiogenesis in postnatal blood vessel development. Effects on VEGF receptors in the adult retinal and choroidal vascular network have not yet been analyzed.

 
Methods
 

Notch intracellular domain (NICD) is the nuclear transcription factor in Notch signaling. NICD gain of function (GOF) mice were laser-treated. Gene expression of VEGFR-1, -2 and 3, of VEGF-A and -C and of Notch-related genes (Jag-1, Dll4, Hey-1, Hes-1) and PECAM-1 were analyzed and in-vivo angiography performed. The distribution of VEGFR-1, -2 and -3 were analyzed immunhistochemically in C57Bl/6 mice.

 
Results
 

Immunhistochemically, membrane-associated VEGFR1 was expressed in the ganglion cell (GC) layer and was only partially associated to blood vessels. VEGFR2 was expressed in the GC layer and weaker in the inner and outer nuclear layer. In CNV, VEGFR2 was not associated specifically to vessel walls but to isolectin B4 (IB4) negative cells in the vessels. The IB4 levels of the neovascular vessel were increased. VEGFR3 could be visualized in the GCs and their axons and in the ILM, in the outer plexiform layer and weakly in the inner plexiform layer. Gene expression analysis showed a strong increase of VEGF-A and -C and VEGFR1 early after laser treatment in NICDGOF mice and a lesser increase of VEGFR2>3. Notch-related genes were upregulated and PECAM1 levels were reduced. These changes diminished over time. 14 days after laser, VEGF-A,-C and VEGFR2 and -3 were decreased. PECAM1 was still reduced. Angiographic analysis on day 7 showed a markedly reduced hyperfluorescence in laser spots of NICDGOF mice compared to littermate controls.

 
Conclusions
 

For the first time, the distribution of VEGFR3 in the retina and choroid was described and investigated as a possible target for angiogenic changes in the adult eye. We could show decreased PECAM1 levels in NICDGOF mice which, together with the observations in angiography, might be due to a lesser amount of endothelial cells. Notch could be a therapeutical target in eye diseases with uncontrolled vessel growth due to its effect on VEGF receptors and their ligands and to reduced vascular permeability.

 
Keywords: 453 choroid: neovascularization • 674 receptors • 412 age-related macular degeneration  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×